Perez-D'Gregorio R E, Miller R K
Department of Obstetrics and Gynecology, University of Rochester, School of Medicine and Dentistry, New York 14642-8668, USA.
J Pediatr. 1998 Mar;132(3 Pt 2):S35-42. doi: 10.1016/s0022-3476(98)70526-8.
The kinetics for vitamin B12, cobalamin (Cbl), transfer across the human placenta, and the retention of the endogenous Cbl and its release into the maternal and fetal compartments were investigated in a dually perfused human term placenta in vitro. After 4 hours of perfusion following a single bolus injection (peak maternal perfusate 94 fmol/ml) of 57Co-Cbl into the maternal reservoir, the maternal [57Co-Cbl] rapidly decreased whereas the fetal [57Co-Cbl] was only 9% of the final maternal [57Co-Cbl]. Even though there was a limited transfer of 57Co-Cbl to the fetus, the placenta rapidly accumulated Cbl. At 4 hours, 18% of the initial 57Co-Cbl dose was in the placenta; only 3% of the initial dose was in the fetal perfusate. Also after 4 hours, [57Co-Cbl] was bound > 95% to transcobalamin (TC)I/III-like proteins in the maternal perfusate, whereas Cbl was bound to TCI/III- and TCII-like proteins with some free in the fetal perfusate. In the cytosol, > 95% of the [57Co-Cbl] was bound (80% to TCII-like and 19% to TCI/III-like proteins). When no exogenous Cbl was added, total endogenous [Cbl] in the maternal circulation increased with time during 8 hours of perfusion at a rate of 0.25 +/- 0.12 pmol/gm per hour. Only 2% of this Cbl was free, whereas 98% was bound to specific binding proteins. Neither plateau values nor equilibration with the fetal side were noted. In the fetal circulation, there was a release of Cbl at a rate of 0.015 +/- 0.003 pmol/gm per hour, which was 99.99% bound. Thus the human placenta rapidly concentrates Cbl in the perfused lobule with little distribution of Cbl to nonperfused areas. Therefore, the human placenta modulates the asymmetric transfer of vitamin B12 on the basis of release of specific Cbl-binding proteins (TCI/III- and TCII-like) into the maternal and fetal perfusates.
在体外双灌注足月人胎盘中,研究了维生素B12(钴胺素,Cbl)跨人胎盘转运的动力学,以及内源性Cbl的保留及其向母体和胎儿区室的释放情况。在向母体储液器单次推注(母体灌注液峰值为94 fmol/ml)57Co-Cbl后进行4小时灌注,母体[57Co-Cbl]迅速下降,而胎儿[57Co-Cbl]仅为母体最终[57Co-Cbl]的9%。尽管57Co-Cbl向胎儿的转运有限,但胎盘迅速积累Cbl。4小时时,初始57Co-Cbl剂量的18%在胎盘中;初始剂量的仅3%在胎儿灌注液中。同样在4小时后,母体灌注液中>95%的[57Co-Cbl]与类转钴胺素(TC)I/III样蛋白结合,而Cbl在胎儿灌注液中与TCI/III样和TCII样蛋白结合且有一些游离。在细胞溶质中,>95%的[57Co-Cbl]被结合(80%与TCII样蛋白结合,19%与TCI/III样蛋白结合)。当不添加外源性Cbl时,在8小时灌注期间母体循环中的总内源性[Cbl]随时间以0.25±0.12 pmol/gm每小时的速率增加。该Cbl中仅2%是游离的,而98%与特异性结合蛋白结合。未观察到平台值或与胎儿侧的平衡。在胎儿循环中,Cbl以0.015±0.003 pmol/gm每小时的速率释放,其结合率为99.99%。因此,人胎盘在灌注小叶中迅速浓缩Cbl,而Cbl向未灌注区域的分布很少。所以,人胎盘基于特异性Cbl结合蛋白(TCI/III样和TCII样)向母体和胎儿灌注液中的释放来调节维生素B12的不对称转运。